Philip Helliwell, PhD DM FRCP
Leeds Institute of Molecular Medicine
Section of Musculoskeletal Disease
University of Leeds
Leeds, England

Philip Helliwell is currently Senior Lecturer in Rheumatology at the University of Leeds, in the UK, and Honorary Consultant Rheumatologist for the Bradford Hospitals NHS Trust.

Previous and current appointments include: Member of NHS R&D Research Committee on Physical and Complex Disabilities, Member of the Executive Council, Centre for Biomechanics and Medical Engineering; Treasurer and Member of Executive Committee, Society for Back Pain Research; Member of Education Committee, Arthritis Research Campaign; and Editor for the ARC Patient Information Leaflets and Convener Publications Working Group, Member of the Heberden Committee, at the British Society for Rheumatology, Member of Council at the British Society for Rheumatology.

Dr Helliwell is a member of ASAS (Assessment of Spondyloarthropathy Society) and co-founder and Vice President of the Group for Research and Assessment of Psoriasis and Psoriatic arthritis (GRAPPA). He has worked with GRAPPA in developing single and composite outcome measures in psoriatic arthritis and has just recruited the first treat to target study in early psoriatic arthritis – due for publication in 2013.

Dr Helliwell is co-founder and co-lead for the Bradford (University) Diploma in Rheumatology and Musculoskeletal Medicine and is an active member of the Bradford and Airedale Musculoskeletal Alliance, a tier 2 service provided to GPs in the designated geographical area.

Current and past research: treatment paradigms, clinical features and classification of psoriatic arthritis; treatment paradigms in psoriatic arthritis; biomechanics of joints, gait assessment and foot disorders in inflammatory and non-inflammatory arthritis, epidemiology of rheumatic disease and community based studies of psoriasis and psoriatic arthritis.